Xtant Medical Holdings, Inc. (XTNT) Earnings History
Net Loss18 years of earnings data (2008–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Xtant Medical Holdings, Inc. (XTNT) Earnings Overview
As of September 25, 2026, Xtant Medical Holdings, Inc. (XTNT) reported trailing twelve-month net income of -$11M, reflecting +125.0% year-over-year growth. The company earned $-0.08 per diluted share over the past four quarters, with a net profit margin of 3.7%.
Looking at the long-term picture, XTNT's historical earnings data spans multiple years. The company achieved its highest annual net income of $5M in fiscal 2025, representing a new all-time high.
Xtant Medical Holdings, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ATEC (-$110M net income, -18.8% margin), NVCR (-$149M net income, -20.8% margin), OSPN ($68M net income, 30.0% margin), XTNT has outperformed on profitability metrics. Compare XTNT vs ATEC →
XTNT Earnings vs Peers
Earnings metrics vs comparable public companies
XTNT Historical Earnings Data (2008–2025)
18 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $5M | +130.2% | $7M | $0.03 | 3.7% | 5.4% |
| 2024 | -$16M | -2592.3% | -$12M | $-0.12 | -14.0% | -10.3% |
| 2023 | $660,000 | +107.8% | -$10M | $0.01 | 0.7% | -11.1% |
| 2022 | -$8M | -75.0% | -$7M | $-0.09 | -14.6% | -11.7% |
| 2021 | -$5M | +31.0% | -$4M | $-0.06 | -8.8% | -7.0% |
| 2020 | -$7M | +14.6% | $-751,000 | $-0.25 | -13.2% | -1.4% |
| 2019 | -$8M | +88.3% | -$2M | $-0.62 | -12.7% | -3.6% |
| 2018 | -$70M | -33.7% | -$60M | $-5.93 | -97.1% | -83.2% |
| 2017 | -$52M | -168.9% | -$38M | $-34.51 | -63.4% | -45.8% |
| 2016 | -$19M | -796.5% | -$8M | $-18.32 | -21.7% | -8.4% |
| 2015 | -$2M | +79.3% | -$12M | $-2.62 | -3.7% | -20.4% |
| 2014 | -$11M | +17.2% | -$6M | $-19.26 | -29.7% | -17.7% |
| 2013 | -$13M | -64.6% | -$9M | $-29.15 | -38.4% | -27.2% |
| 2012 | -$8M | -156.6% | -$5M | $-19.83 | -23.4% | -15.0% |
| 2011 | -$3M | +84.6% | -$6M | $-8.43 | -10.0% | -21.4% |
| 2010 | -$19M | -371.9% | -$9M | $-66.03 | -126.3% | -55.9% |
| 2009 | -$4M | -25938.1% | -$4M | $-17.02 | -55.8% | -49.0% |
| 2008 | $-15,845 | - | $-15,845 | $-0.07 | -3.5% | -3.5% |
Download Data
Export XTNT earnings history in CSV or JSON format
Free sign-in required to download data
XTNT Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
18+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
XTNT — Frequently Asked Questions
Quick answers to the most common questions about buying XTNT stock.
What is XTNT earnings per share (EPS)?
XTNT trailing twelve-month (TTM) diluted EPS is $-0.08, reflecting +125.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2008 to 2025 is available in the table on this page.
What is Xtant Medical Holdings, Inc.'s net income?
Xtant Medical Holdings, Inc. (XTNT) trailing twelve-month net income is $-11M as of 2025. Earnings grew +125.0% year-over-year.
Is XTNT profitable?
XTNT is not currently profitable on a TTM basis, reporting a net loss of $-11M. Net margin is +3.7%. Investors should monitor for a return to profitability.
What is XTNT's earnings growth rate?
XTNT compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2008 to 2025.
What are XTNT's profit margins?
Xtant Medical Holdings, Inc. net profit margin is +3.7%, operating margin is +5.4%, and gross margin is +62.9%. Below-average margins reflect competitive or cost pressures. Return on Equity is +10.6%.
Is XTNT growing earnings?
Yes, XTNT earnings are accelerating — EPS growth of +125.0% exceeds the 5-year CAGR of N/A. TTM net income reached $-11M. Earnings momentum is strengthening.
What was XTNT's best earnings year?
Xtant Medical Holdings, Inc.'s highest annual net income on record is $5M, achieved in fiscal year 2025. Earnings history on this page spans 2008 to 2025 and includes all annual and quarterly figures.
What were XTNT's earnings last quarter?
XTNT's most recent reported quarter was Q2 2026. Net income was $-9M with diluted EPS of $-0.07. For a full breakdown of all quarters, see the quarterly earnings table on this page.